Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Mar;81(3):918–923. doi: 10.1172/JCI113403

Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.

E S Schulman 1, T J Post 1, P M Henson 1, P C Giclas 1
PMCID: PMC442545  PMID: 2449462

Abstract

The ability of purified anaphylatoxins to induce human lung mast cell mediator release was investigated. In eight anti-IgE responsive (histamine release = 22 +/- 5%, mean +/- SEM) mast cell preparations of 1-96% purity, C5a and C5a des Arg (0.55 pg/ml to 55 micrograms/ml), failed to elicit or potentiate histamine release; lung fragments were similarly unresponsive. The related peptide C3a was also inactive. All anaphylatoxins failed to induce mast cell leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) release. LTC4 release was also negligible from basophils where C5a was a potent histamine release stimulus. Supernatants from C5a-challenged mast cells remained fully active on basophils, excluding carboxypeptidase inactivation of C5a as an explanation for the lung mast cell results. In contrast to lung, skin mast cells were C5a-responsive (histamine release = 8 +/- 1%, at 55 micrograms/ml, n = 2). We conclude that C5a, though devoid of activity on the human lung mast cell, is a human basophil and skin mast cell secretagogue. These findings demonstrate significant organ-specific heterogeneity in mast cell responsiveness.

Full text

PDF
918

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austen K. F., Orange R. P. Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis. 1975 Sep;112(3):423–436. doi: 10.1164/arrd.1975.112.3.423. [DOI] [PubMed] [Google Scholar]
  2. Benyon R. C., Lowman M. A., Church M. K. Human skin mast cells: their dispersion, purification, and secretory characterization. J Immunol. 1987 Feb 1;138(3):861–867. [PubMed] [Google Scholar]
  3. Bienenstock J., Befus A. D., Pearce F., Denburg J., Goodacre R. Mast cell heterogeneity: derivation and function, with emphasis on the intestine. J Allergy Clin Immunol. 1982 Dec;70(6):407–412. doi: 10.1016/0091-6749(82)90001-x. [DOI] [PubMed] [Google Scholar]
  4. Camussi G., Tetta C., Bussolino F., Caligaris Cappio F., Coda R., Masera C., Segoloni G. Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. Int Arch Allergy Appl Immunol. 1981;64(1):25–41. doi: 10.1159/000232671. [DOI] [PubMed] [Google Scholar]
  5. Cochrane C. G., Müller-Eberhard H. J. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med. 1968 Feb 1;127(2):371–386. doi: 10.1084/jem.127.2.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dahinden C. A., Clancy R. M., Gross M., Chiller J. M., Hugli T. E. Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6632–6636. doi: 10.1073/pnas.82.19.6632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farnam J., Grant J. A., Lett-Brown M. A., Hunt C., Thueson D. O., Giclas P. C. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism. J Immunol. 1985 Jan;134(1):541–547. [PubMed] [Google Scholar]
  8. Gerard C., Hugli T. E. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1833–1837. doi: 10.1073/pnas.78.3.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gilbert H. S., Ornstein L. Basophil counting with a new staining method using alcian blue. Blood. 1975 Aug;46(2):279–286. [PubMed] [Google Scholar]
  10. Huey R., Bloor C. M., Kawahara M. S., Hugli T. E. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue. Am J Pathol. 1983 Jul;112(1):48–60. [PMC free article] [PubMed] [Google Scholar]
  11. Hugli T. E. Structure and function of the anaphylatoxins. Springer Semin Immunopathol. 1984;7(2-3):193–219. doi: 10.1007/BF01893020. [DOI] [PubMed] [Google Scholar]
  12. Ishizaka T., Conrad D. H., Schulman E. S., Sterk A. R., Ishizaka K. Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. J Immunol. 1983 May;130(5):2357–2362. [PubMed] [Google Scholar]
  13. Johnson A. R., Hugli T. E., Müller-Eberhard H. J. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 1975 Jun;28(6):1067–1080. [PMC free article] [PubMed] [Google Scholar]
  14. Kreutzer D. L., Desai U., Orr W., Showell H., Ward P. A. Induction of acute inflammatory reactions in lung following intrapulmonary instillation of preformed chemotactic peptides and purified complement components. Chest. 1979 Feb;75(2 Suppl):259–262. doi: 10.1378/chest.75.2_supplement.259. [DOI] [PubMed] [Google Scholar]
  15. LICHTENSTEIN L. M., OSLER A. G. STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN. J Exp Med. 1964 Oct 1;120:507–530. doi: 10.1084/jem.120.4.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lampe M., Kiernan J. A. Cytochemical variation of mast cells in the skin of the rat. Arch Dermatol Res. 1977 Mar 25;258(1):69–80. doi: 10.1007/BF00582869. [DOI] [PubMed] [Google Scholar]
  17. Lepow I. H., Willms-Kretschmer K., Patrick R. A., Rosen F. S. Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man. Am J Pathol. 1970 Oct;61(1):13–23. [PMC free article] [PubMed] [Google Scholar]
  18. MacGlashan D. W., Jr, Schleimer R. P., Peters S. P., Schulman E. S., Adams G. K., 3rd, Newball H. H., Lichtenstein L. M. Generation of leukotrienes by purified human lung mast cells. J Clin Invest. 1982 Oct;70(4):747–751. doi: 10.1172/JCI110670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Narumiya S., Ogorochi T., Nakao K., Hayaishi O. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 1982 Nov 8;31(19):2093–2103. doi: 10.1016/0024-3205(82)90101-1. [DOI] [PubMed] [Google Scholar]
  20. Peters S. P., MacGlashan D. W., Jr, Schulman E. S., Schleimer R. P., Hayes E. C., Rokach J., Adkinson N. F., Jr, Lichtenstein L. M. Arachidonic acid metabolism in purified human lung mast cells. J Immunol. 1984 Apr;132(4):1972–1979. [PubMed] [Google Scholar]
  21. Pinckard R. N., Farr R. S., Hanahan D. J. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol. 1979 Oct;123(4):1847–1857. [PubMed] [Google Scholar]
  22. Regal J. F., Eastman A. Y., Pickering R. J. C5a induced tracheal contraction: a histamine independent mechanism. J Immunol. 1980 Jun;124(6):2876–2878. [PubMed] [Google Scholar]
  23. Schulman E. S., Adkinson N. F., Jr, Newball H. H. Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):589–595. doi: 10.1152/jappl.1982.53.3.589. [DOI] [PubMed] [Google Scholar]
  24. Schulman E. S., Kagey-Sobotka A., MacGlashan D. W., Jr, Adkinson N. F., Jr, Peters S. P., Schleimer R. P., Lichtenstein L. M. Heterogeneity of human mast cells. J Immunol. 1983 Oct;131(4):1936–1941. [PubMed] [Google Scholar]
  25. Schulman E. S., MacGlashan D. W., Jr, Peters S. P., Schleimer R. P., Newball H. H., Lichtenstein L. M. Human lung mast cells: purification and characterization. J Immunol. 1982 Dec;129(6):2662–2667. [PubMed] [Google Scholar]
  26. Schulman E. S., MacGlashan D. W., Jr, Schleimer R. P., Peters S. P., Kagey-Sobotka A., Newball H. H., Lichtenstein L. M. Purified human basophils and mast cells: current concepts of mediator release. Eur J Respir Dis Suppl. 1983;128(Pt 1):53–61. [PubMed] [Google Scholar]
  27. Schulman E. S., Newball H. H., Demers L. M., Fitzpatrick F. A., Adkinson N. F., Jr Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis. 1981 Oct;124(4):402–406. doi: 10.1164/arrd.1981.124.4.402. [DOI] [PubMed] [Google Scholar]
  28. Shaw J. O., Henson P. M., Henson J., Webster R. O. Lung inflammation induced by complement-derived chemotactic fragments in the alveolus. Lab Invest. 1980 May;42(5):547–558. [PubMed] [Google Scholar]
  29. Siraganian R. P., Hook W. A. Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction. J Immunol. 1976 Mar;116(3):639–646. [PubMed] [Google Scholar]
  30. Stimler N. P., Bach M. K., Bloor C. M., Hugli T. E. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin. J Immunol. 1982 May;128(5):2247–2252. [PubMed] [Google Scholar]
  31. Stimler N. P., Brocklehurst W. E., Bloor C. M., Hugli T. E. Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response. J Immunol. 1981 Jun;126(6):2258–2261. [PubMed] [Google Scholar]
  32. Vallota E. H., Müller-Eberhard H. J. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J Exp Med. 1973 May 1;137(5):1109–1123. doi: 10.1084/jem.137.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Webster R. O., Henson P. M. Rapid micromeasurement of neutrophil exocytosis. Inflammation. 1978 Jun;3(2):129–135. doi: 10.1007/BF00910734. [DOI] [PubMed] [Google Scholar]
  34. Webster R. O., Hong S. R., Johnston R. B., Jr, Henson P. M. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology. 1980 Jun;2(3):201–219. doi: 10.1016/0162-3109(80)90050-8. [DOI] [PubMed] [Google Scholar]
  35. Williams T. J., Jose P. J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med. 1981 Jan 1;153(1):136–153. doi: 10.1084/jem.153.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wuepper K. D., Bokisch V. A., Müller-Eberhard H. J., Stoughton R. B. Cutaneous responses to human C 3 anaphylatoxin in man. Clin Exp Immunol. 1972 May;11(1):13–20. [PMC free article] [PubMed] [Google Scholar]
  37. Yancey K. B., Hammer C. H., Harvath L., Renfer L., Frank M. M., Lawley T. J. Studies of human C5a as a mediator of inflammation in normal human skin. J Clin Invest. 1985 Feb;75(2):486–495. doi: 10.1172/JCI111724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. van Epps D. E., Chenoweth D. E. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes. J Immunol. 1984 Jun;132(6):2862–2867. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES